EVI2B and Alzheimer disease: Lysosome‐associated genes ATP6V1E1 and immune response‐related genes (IL2RG, OSM, EVI2B TNFRSF1A, CXCR4, STAT5A) were significantly correlated with Aβ or Tau pathology, which may be candidate targets for AD treatment.